Form 4: Tharimmune COO Acquires 5,000 Stock Options
Insider Transaction Report
Tharimmune's Chief Operating Officer, Sanam Parikh, acquired 5,000 stock options exercisable at $3.075 per share, increasing total beneficial ownership to 55,000 options.
Summary
- Sanam Parikh, who serves as a Director and Chief Operating Officer (COO) of Tharimmune, Inc. [THAR], acquired 5,000 stock options.
- The transaction date for the acquisition of these derivative securities was November 3, 2025.
- Each stock option has an exercise price of $3.075.
- The options become exercisable on November 3, 2025, and have an expiration date of November 3, 2035.
- Following this transaction, Sanam Parikh directly beneficially owns a total of 55,000 stock options.
- The underlying security for these options is 5,000 shares of Common Stock.
Sentiment
Score: 7
Explanation: The acquisition of additional stock options by a key executive (COO and Director) is generally viewed as a positive signal, indicating confidence in the company's future and aligning management's incentives with shareholder value creation.
Positives
- The acquisition of 5,000 stock options by the Chief Operating Officer and Director, Sanam Parikh, signals management's confidence in the company's future prospects.
- The increase in insider beneficial ownership aligns the interests of management with those of shareholders, potentially motivating performance.
Future Outlook
This filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This insider transaction reflects an individual executive's compensation and investment activity within Tharimmune, Inc. and does not provide broader industry context or trends.
Related Party Transactions
- The acquisition of stock options by Sanam Parikh, a Director and COO, from Tharimmune, Inc. constitutes a transaction between the company and a related party (an insider) as part of executive compensation.
Stakeholder Impact
- Shareholders may interpret the insider's acquisition of options as a positive indicator of management's belief in the company's future growth and value, potentially boosting investor confidence.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Transaction date for the acquisition of stock options. |
| 11/03/2025 | Date when the acquired stock options become exercisable. |
| 11/05/2025 | Date the Form 4 was signed by Sanam Parikh. |
| 11/03/2035 | Expiration date of the acquired stock options. |
Keywords
Tharimmune, THAR, Stock Options, Insider Transaction, Form 4, Beneficial Ownership, Sanam Parikh, COO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.